Maturation and growth of renal function: Dosing renally cleared drugs in children

被引:0
|
作者
Hayton W.L. [1 ]
机构
[1] Division of Pharmaceutics, College of Pharmacy, Ohio State University, Columbus, OH 43210-1291
来源
AAPS PharmSci | / 2卷 / 1期
关键词
Renal Function;
D O I
10.1208/ps020103
中图分类号
学科分类号
摘要
A model was developed that characterized the maturation and growth of the renal function parameters (RFPs) glomerular filtration rate (GF), active tubular secretion (AS), and renal plasma flow (Q R). Published RFP values were obtained from 63 healthy children between the ages of 2 days and 12 years. Maturation over time was assumed to be exponential from an immature (RFP im) to a mature (RFP ma) level; for growth, RFP im and RFP ma were assumed to follow the allometric equation: RFP (age, W) = aWb e-kmat*age + cWb (1 - e-kmat*age), where W is body weight, k mat is the maturation rate constant, b is the body weight exponent, and a and c are RFP im and RFP ma at unit W. The model-based equation was fitted to the age-W, RFP values by a nonlinear least-squares method. For GF, the maturation half-life was 7.9 months (90% maturation, 26 months), the body weight exponent was 0.662, and the ratio c/a (which reflected the magnitude of the maturation influence) was 3.1. For AS and QR, the maturation half-lives were about 3.8 months and the ratio c/a was about 1.8. For renally eliminated drugs, the model can be used to estimate dosing regimens that are based on the adult dosing regimen and the age and weight of the child.
引用
收藏
页码:22 / 28
页数:6
相关论文
共 50 条
  • [41] Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal function
    de Cacqueray, Noemie
    Hirt, Deborah
    Zheng, Yi
    Bille, Emmanuelle
    Leger, Pierre Louis
    Rambaud, Jerome
    Toubiana, Julie
    Chosidow, Anais
    Vimont, Sophie
    Callot, Delphine
    Chouchana, Laurent
    Beranger, Agathe
    Treluyer, Jean Marc
    Benaboud, Sihem
    Oualha, Mehdi
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (10) : 1389.e1 - 1389.e7
  • [42] Dosing tuberculosis drugs in young children: the road ahead
    Pasipanodya, Jotam G.
    Gumbo, Tawanda
    LANCET CHILD & ADOLESCENT HEALTH, 2019, 3 (09): : 590 - 592
  • [43] Investigating current practices in renal function measurement and carboplatin dosing in children with cancer - a UK perspective
    Roberts, Eve
    Mogg, Jasper A. W.
    Barnfield, Mark
    Veal, Gareth J.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2020, 37 (03) : 235 - 244
  • [44] Renal function and antiplatelet drugs
    Keltai, Matyas M. D.
    CORONARY ARTERY DISEASE: 2011 UPDATE: FROM PREVENTION TO INTERVENTION, 2011, : 263 - 268
  • [45] Growth hormone and markers of immune function in children with renal transplants
    Maxwell, H
    Amlot, P
    Rees, L
    PEDIATRIC NEPHROLOGY, 2000, 14 (06) : 473 - 475
  • [46] GROWTH AND ENDOCRINE FUNCTION IN CHILDREN WITH CHRONIC-RENAL-FAILURE
    RIGDEN, SPA
    REES, L
    CHANTLER, C
    ACTA PAEDIATRICA SCANDINAVICA, 1990, : 20 - 27
  • [47] Growth hormone and markers of immune function in children with renal transplants
    H. Maxwell
    P. Amlot
    L. Rees
    Pediatric Nephrology, 2000, 14 : 473 - 475
  • [48] omGFR! - update on renal dosing anticancer drugs in frail patients
    Sandhu, Geeta
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 54 - 54
  • [49] Growth and maturation improvement in children on renal replacement therapy over the past 20 years
    Franke, Doris
    Winkel, Stella
    Gellermann, Jutta
    Querfeld, Uwe
    Pape, Lars
    Ehrich, Jochen H. H.
    Haffner, Dieter
    Pavicic, Leo
    Zivicnjak, Miroslav
    PEDIATRIC NEPHROLOGY, 2013, 28 (10) : 2043 - 2051
  • [50] Growth and maturation improvement in children on renal replacement therapy over the past 20 years
    Doris Franke
    Stella Winkel
    Jutta Gellermann
    Uwe Querfeld
    Lars Pape
    Jochen H. H. Ehrich
    Dieter Haffner
    Leo Pavičić
    Miroslav Živičnjak
    Pediatric Nephrology, 2013, 28 : 2043 - 2051